Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Matthew Abbott

Matthew Abbott is recorded as CFO at Chemours Co (CC). Chemours Co reported in an 8-K filed February 29, 2024 that Matthew Abbott was appointed Interim Chief Financial Officer, effective February 28, 2024. Chemours Co reported in an 8-K filed June 6, 2023 that Matthew Abbott was appointed Senior Vice President, Chief Enterprise Transformation Officer, effective June 6, 2023.

“On February 28, 2024, the Board of Directors of The Chemours Company ("Chemours" or the "Company") appointed Denise Dignam as the Interim Chief Executive Officer and Matthew Abbott as the Interim Chief Financial Officer (principal financial and accounting officer).”
Chemours Co Form 8-K, filed February 29, 2024 · Read the filing
“Additionally, Matthew Abbott, Vice President, Digital and Data Analytics Leader, is appointed Senior Vice President, Chief Enterprise Transformation Officer, effective June 6, 2023.”
Chemours Co Form 8-K, filed June 6, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Chemours Co

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.